Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances

Pharmacology Research and Perspectives

Volumn 3, Issue 2, 2015, Pages 1-11

  Li, Gen ^a   Nakagome, Izumi ^a   Hirono, Shuichi ^a   Itoh, Tomoo ^a   Fujiwara, Ryoichi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

ADA; Adenosine deaminase; Docking study; Enzyme inhibition; Naringin

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; AURANTIIN; CORDYCEPIN; KAEMPFEROL; MYRICETIN; NARINGENIN; QUERCETIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DEAMINATION; DRUG METABOLISM; HEK293 CELL LINE; HUMAN; HUMAN TISSUE; INTRINSIC CLEARANCE; JURKAT CELL LINE; MOLECULAR DOCKING; MTT ASSAY; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 84975197710     PISSN: None     EISSN: 20521707     Source Type: Journal    
DOI: 10.1002/prp2.121     Document Type: Article

References (38)

1. Adamson RH, Zaharevitz DW, Johns DG (1977). Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin. Pharmacology 15: 84-89.
2. Agarwal RP, Spector T, Parks RE Jr (1977). Tight-binding inhibitors IV. Inhibition of adenosine deaminase by various inhibitors. Biochem Pharmacol 26: 359-367.
3. Andreasyan NA, Hairapetyan HL, Sargisova YG, Mardanyan SS (2005). ADA2 isoform of adenosine deaminase from pleural fluid. FEBS Lett 579: 643-647.
4. Bhattarai NK (1993). Folk herbal medicines of Dolakha district, Nepal. FITOTERAPIA-MILANO- 64: 387.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Bukulmez G, Akan T, Ciliv G (2000). Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. European Journal of Dermatology 10: 274-276.
7. Cristalli G, Eleuteri A, Vittori S, Volpini R, Camaioni E, Lupidi G (1993). Adenosine deaminase inhibitors structure activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs. Drug Dev Res 28: 253-258.
8. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, et al. (2001). Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 21: 105-128.
9. Cunningham KG, Manson W, Spring FS, Hutchinson SA (1950). Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 166: 949.
10. Dalla RL, da Silva AS, Gressler LT, Oliveira CB, Dambrós MG, Miletti LC, et al. (2013). Cordycepin (3'-deoxyadenosine) pentostatin (deoxycoformycin) combination treatment of mice experimentally infected with Trypanosoma evansi. Parasitology 140: 663-671.
11. Dong RP, Tachibana K, Hegen M, Munakata Y, Cho D, Schlossman SF, et al. (1997). Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. J Immunol 159: 6070-6076.
12. Frederiksen S, Malling H, Klenow H (1965). Isolation of 3'-deoxyadenosine (cordycepin) from the liquid medium of Cordyceps militaris. Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein. Synthesis 95: 189-193.
13. Gakis C (1996). Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 9: 632-633.
14. Glazer RI, Lott TJ, Peale AL (1978). Potentiation by 2'-deoxycoformycin of the inhibitory effect by 3'-deoxyadenosine (Cordycepin) on nuclear RNA synthesis in L1210 cells in vitro. Cancer Res 38: 2233-2238.
15. Gong XJ, Ji H, Lu SG, Li SP, Li P (2000). Effects of polysaccharides from cultured cordyceps sinensis on murine immunologic function. Zhongguo Yaoke Daxue Xuebao 31: 53-55.
16. Handa K, Nakagome I, Yamaotsu N, Gouda H, Hirono S (2013). Three-dimensional quantitative structure-activity relationship analysis of inhibitors of human and rat cytochrome P4503A enzymes. Drug Metab Pharmacokinet 28: 345-355.
17. Ikeda R, Nishimura M, Sun Y, Wada M, Nakashima K (2008). Simple HPLC-UV determination of nucleosides and its application to the authentication of Cordyceps and its allies. Biomed Chromatogra 22: 630-636.
18. Johns DG, Adamson RH (1976). Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin. BiochemPharmacol 25: 1441-1444.
19. Koch HP, Jäger W, Groh U, Plank G (1992). In vitro inhibition of adenosine deaminase by flavonoids and related compounds. New insight into the mechanism of action of plant phenolics. Methods Find Exp Clin Pharmacol 14: 413-417.
20. Koyama K, Imaizumi T, Akiba M, Kinoshita K, Takahashi K, Suzuki A, et al. (1997). Antinociceptive components of Ganoderma lucidum. Planta Med 63: 224-227.
21. Kraut EH, Neff JC, Bouroncle BA, Gochnour D, Grever MR (1990). Immunosuppressive effects of pentostatin. J Clin Oncol 8: 848-855.
22. Leach JW, Pham T, Diamandidis D, George JN (1999). Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): a case report. Am J Hematol 61: 268-270.
23. Lee HJ, Burger P, Vogel M, Friese K, Brüning A (2012). The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells. Invest New Drugs 30: 1917-1925.
24. Melzig MF (1996). Inhibition of adenosine deaminase activity of aortic endothelial cells by selected flavonoids. Planta Med 62: 20-21.
25. Meyskens FL, Williams HE (1971). Adenosine metabolism in human erythrocytes. Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein. Synthesis 240: 170-179.
26. North TW, Cohen SS (1978). Erythro-9-(2-hydroxy-3-nonyl) adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues. Proc Natl Acad Sci 75: 4684-4688.
27. Ozsahin H, Arredondo-Vega FX, Santisteban I, Fuhrer H, Tuchschmid P, Jochum W, et al. (1997). Adenosine deaminase deficiency in adults. Blood 89: 2849-2855.
28. Ratech H, Thorbecke GJ, Meredith G, Hirschhorn R (1981). Comparison and possible homology of isozymes of adenosine deaminase in Aves and Humans. Enzyme 26: 74-84.
29. Sargisova YG, Andreasyan NA, Hayrapetyan HL, Harutyunyan HA (2012). Nitric oxide - an activating factor of adenosine deaminase 2 in vitro. Biochemistry (Mosc). 77: 92-97.
30. Shipman C, Smith SH, Carlson RH, Drach JC (1976). Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Antimicrob Agents Chemother 9: 120-127.
31. Spiers AS, Parekh SJ, Bishop MB (1984). Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin). J Clin Oncol 2: 1336-1342.
32. Sugar AM, McCaffrey RP (1998). Antifungal Activity of 3'-Deoxyadenosine (Cordycepin). Antimicrob Agents Chemother 42: 1424-1427.
33. Terasaka T, Nakanishi I, Nakamura K, Eikyu Y, Kinoshita T, Nishio N, et al. (2003). Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorg Med Chem Lett 13: 1115-1118.
34. Terasaka T, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, et al. (2005). Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism. J Med Chem 48: 4750-4753.
35. Tsai YJ, Lin LC, Tsai TH (2010). Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in Rat. J Agric Food Chem 58: 4638-4643.
36. Wu WC, Hsiao JR, Lian YY, Lin CY, Huang BM (2007). The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol 60: 103-111.
37. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M (2000). Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res 14: 647-649.
38. Yoshikawa N, Nakamura K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M (2004). Antitumour activity of cordycepin in mice. Clin Exp Pharmacol Physiol Suppl 2: S51-S53.